Target intelligence / Profile preview

Activated Cdc42-associated kinase (None)

Target
None
Molecular classification
Enzyme, Non-receptor tyrosine-protein kinase, Serine/threonine-protein kinase
01

Overview

Activated Cdc42-associated kinase (ACK), also known as ACK1 or TNK2, is a non-receptor tyrosine kinase that acts as an effector for the small GTPase Cdc42. It plays a significant role in transducing extracellular signals to cytosolic and nuclear effectors, impacting various cellular processes such as cell spreading, migration, survival, growth, and proliferation. ACK's dysregulation is implicated in various cancers, making it a potential therapeutic target.

Other names
ACK1TNK2
02

Mechanism of action

Tyrosine kinase inhibition (potential)

03

Biological functions

Signal transductionCell spreadingCell migrationCell survivalCell growthCell proliferationRegulation of protein homeostasisClathrin-mediated endocytosisSynaptic function/plasticityBrain development
04

Disease associations

Cancer
05

Safety considerations

Lack of specific inhibitors in clinical trialsPotential for off-target effects due to kinase family conservation

Beyond the preview

Go deeper on Activated Cdc42-associated kinase (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Activated Cdc42-associated kinase (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call